Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triple Negative Breast Neoplasms | 10 | 2026 | 286 | 3.050 |
Why?
|
| Mitochondria | 3 | 2026 | 765 | 0.870 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2023 | 23 | 0.810 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 241 | 0.770 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2026 | 999 | 0.640 |
Why?
|
| RNA-Binding Proteins | 3 | 2013 | 551 | 0.640 |
Why?
|
| Breast | 1 | 2020 | 217 | 0.600 |
Why?
|
| Doxorubicin | 2 | 2026 | 301 | 0.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2026 | 2018 | 0.590 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 1813 | 0.570 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 447 | 0.530 |
Why?
|
| Neoadjuvant Therapy | 4 | 2025 | 407 | 0.530 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 709 | 0.520 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2026 | 823 | 0.500 |
Why?
|
| Ribonucleoproteins | 2 | 2015 | 57 | 0.430 |
Why?
|
| Alternative Splicing | 2 | 2013 | 313 | 0.430 |
Why?
|
| Receptor, Insulin | 2 | 2013 | 62 | 0.430 |
Why?
|
| Introns | 2 | 2015 | 288 | 0.410 |
Why?
|
| Cell Line, Tumor | 7 | 2026 | 3708 | 0.390 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1620 | 0.370 |
Why?
|
| Exons | 2 | 2013 | 769 | 0.360 |
Why?
|
| Microsatellite Repeats | 1 | 2012 | 232 | 0.340 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2656 | 0.320 |
Why?
|
| Neoplasms | 2 | 2024 | 2968 | 0.320 |
Why?
|
| Tumor Microenvironment | 2 | 2026 | 704 | 0.310 |
Why?
|
| Mice, SCID | 3 | 2020 | 579 | 0.300 |
Why?
|
| RNA | 1 | 2012 | 530 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 1226 | 0.280 |
Why?
|
| Animals | 12 | 2026 | 34246 | 0.240 |
Why?
|
| Biological Specimen Banks | 1 | 2025 | 63 | 0.230 |
Why?
|
| Transcriptome | 2 | 2024 | 1138 | 0.220 |
Why?
|
| Genes, Mitochondrial | 1 | 2024 | 19 | 0.210 |
Why?
|
| Spliceosomes | 2 | 2015 | 47 | 0.210 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 520 | 0.190 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 276 | 0.190 |
Why?
|
| Humans | 18 | 2026 | 132012 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2023 | 130 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 4688 | 0.180 |
Why?
|
| Cyclophosphamide | 2 | 2026 | 440 | 0.180 |
Why?
|
| Proteogenomics | 1 | 2022 | 108 | 0.170 |
Why?
|
| Transcription, Genetic | 1 | 2026 | 1398 | 0.170 |
Why?
|
| Mice | 7 | 2026 | 18381 | 0.160 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 134 | 0.160 |
Why?
|
| Software | 1 | 2024 | 752 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 771 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 804 | 0.140 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 360 | 0.140 |
Why?
|
| Prognosis | 2 | 2026 | 4959 | 0.130 |
Why?
|
| Splicing Factor U2AF | 2 | 2015 | 9 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 635 | 0.130 |
Why?
|
| Biopsy | 1 | 2020 | 1253 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1360 | 0.130 |
Why?
|
| Immediate-Early Proteins | 1 | 2016 | 57 | 0.120 |
Why?
|
| HeLa Cells | 2 | 2015 | 694 | 0.120 |
Why?
|
| Genes, myc | 1 | 2015 | 95 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2364 | 0.110 |
Why?
|
| Female | 9 | 2026 | 71358 | 0.110 |
Why?
|
| Disease Progression | 1 | 2020 | 2228 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 92 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 489 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2012 | 6 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 738 | 0.090 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 121 | 0.090 |
Why?
|
| Myotonic Dystrophy | 1 | 2012 | 120 | 0.080 |
Why?
|
| Fragile X Syndrome | 1 | 2012 | 148 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 1299 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1545 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2478 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1403 | 0.070 |
Why?
|
| Mutation | 1 | 2020 | 6195 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2026 | 2582 | 0.060 |
Why?
|
| Apoptosis | 2 | 2026 | 1863 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 35 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 19 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 80 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 131 | 0.050 |
Why?
|
| Cisplatin | 1 | 2023 | 286 | 0.040 |
Why?
|
| Quinuclidines | 1 | 2020 | 7 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2020 | 32 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 301 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 195 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 361 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 117 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 874 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 850 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 613 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 388 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1847 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 42 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 52 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 78 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 195 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 237 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 713 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 432 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 850 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 611 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2010 | 14 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 719 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 519 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1148 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 2423 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2783 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3535 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 2591 | 0.010 |
Why?
|